BioCentury
ARTICLE | Financial News

Cell Therapeutics proposes follow-on

July 14, 2004 7:00 AM UTC

Cancer company Cell Therapeutics (CTIC; NMerc:CTIC) proposed to sell 8 million shares in a follow-on underwritten by UBC; CIBC World Markets; WR Hambrecht; Delafield Hambrecht; and Punk Ziegel. If sol...